A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited ...

Macrophage checkpoint inhibitors promise a transformative role in cancer immunotherapy; by targeting the “don’t eat me” ...

Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana Therapeutics presented additional positive interim Phase 1 clinical data for ...

A new study from ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & ...

No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...

These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

The study was published in the journal Molecular Cancer Research. It shows that insulin resistance—a condition linked to Type ...

If you’re a cancer survivor, there’s no reason to be alone. Join the many amazing women and “a few awesome men” by becoming one of Shay’s Warriors. Visit shayswarriors.org or call 760-895-1705 for ...

Tyler Bremner was picked by the Angels on July 13. Three days earlier, his family had held a celebration of life for his ...

While the incidence of breast cancer is highest for white women, Black women are more likely to have early-onset or more ...

USA: A large retrospective study found that young women diagnosed with breast cancer have a relatively low risk of isolated locoregional recurrence (LRR) after initial treatment. Researchers concluded ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...